View Older Stories
-
Novavax to Participate in Upcoming Investor Conferences
-
S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs
-
Novavax (NVAX) PT Lowered to $15 at Citi
-
Novavax (NVAX) PT Lowered to $0.95 at Citi
-
Pre-Open Stock Movers 04/10: (BRSS) (TPX) (LEVI) Higher; (PTE) (PHAS) (ABC) Lower (more...)
-
Novavax (NVAX) PT Lowered to $1.25 at Citi; Maintains Buy on 3 Upside Opportunities
-
Novavax to Participate at Two Upcoming Investor Conferences
-
Novavax to Participate at Two Upcoming Investor Conferences
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
Novavax (NVAX) Prices 30.3M Share Common Offering at $1.65/Sh
-
Novavax Prices Public Offering of Common Stock
-
Novavax Prices Public Offering of Common Stock
-
Novavax Prices Public Offering of Common Stock
-
Novavax (NVAX) to Offer Common Stock
-
Novavax Announces Proposed Public Offering of Common Stock
-
Novavax Announces Proposed Public Offering of Common Stock
-
Novavax (NVAX) Releases Promising Data on NanoFlu Vaccine, Prompting Upgrade at Citi
-
Citi Upgrades Novavax (NVAX) to Buy
-
Novavax (NVAX) PT Raised to $2.75 at Citi Citing Underappreciated Vaccine
-
Novavax (NVAX): PT Increases to $2 on Ph3 RSV Vax Info Analysis - Citi
-
Citi Comments on Novavax (NVAX), Believes New Data Will Drive Investors to Give More Credit To Success of Trial
-
Citi Downgrades Novavax (NVAX) to Neutral
-
Pre-Open Movers 10/31: (NVAX) (GERN) (PLUG) Higher; (UA) (VYGR) (QCOM) Lower (more...)
-
UPDATE: Citi Upgrades Novavax (NVAX) to Buy
-
Novavax to Participate in the Citi 12th Annual Biotech Conference
-
Novavax to Participate in the Citi 2016 Global Healthcare Conference
-
Pre-Open Stock Movers 09/22: (WCIC) (AVXL) (NVAX) Higher; (MLHR) (JBL) (CPK) Lower (more...)
-
Pre-Open Stock Movers 09/16: (DEPO) (INTC) (GPRO) Higher; (NVAX) (DB) (ORCL) Lower (more...)
-
Citi Downgrades Novavax (NVAX) to Neutral
-
Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day
-
Novavax Announces Exercise of Over-Allotment Option to Purchase Additional Shares
-
Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023
-
Novavax (NVAX) Prices Upsized $300M Conv. Notes Offering
-
Novavax Prices $300 Million of Convertible Senior Notes Due 2023
-
Pre-Open Stock Movers 01/25: (AFMD) (GRUB) (SUNE) (TYC) Higher; (OMED) (NVAX) (TWTR) Lower (more...)
-
Novavax (NVAX) Announces $200M Conv. Senior Notes Offering
-
Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023
-
Novavax to Participate in Multiple Investor Conferences in September
-
Notable 52-Week Highs and Lows 7/10: (WBA) (NVAX) (CVC) High; (Z) (ORC) (TRUE) Low
-
Pre-Open Stock Movers 07/09: (CRV) (MM) (VNET) Higher; (QLGC) (ANTH) (WDFC) Lower (more...)
-
Novavax's (NVAX) Price Target Raised to $18 at Citi
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
Three Small Cap Biotech Stocks Added to Citi's Most Preferred List (ATRA) (NVAX) (PBYI)
-
Novavax (NVAX) Prices 24.14M Common Offering at $7.25/Share
-
Novavax Prices Public Offering of Common Stock
-
Novavax (NVAX) to Offer $175M in Common Stock
-
Novavax Announces Proposed Public Offering of Common Stock

